IRATUMUMAB
UNII AYH22O1B1U

Substance Identification & Data

This profile provides standardized clinical and technical data for Iratumumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) AYH22O1B1U.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 640735-09-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
AYH22O1B1U
CAS Registry Number
640735-09-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
IRATUMUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
8713
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
RR-14
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Iratumumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

IRATUMUMAB

Common Names & Synonyms

HUMAN IMMUNOGLOBIN ANTI-CD30 MONOCLONAL ANTIBODY
IRATUMUMAB [INN]
IRATUMUMAB [USAN]
IRATUMUMAB [WHO-DD]

Technical Codes

MDX-060